Freestone Grove Partners’s Alignment Healthcare ALHC Stock Holding History
Bought
Maintained
Sold
Other funds holding ALHC
Freestone Grove Partners's ALHC Position: Q2 2026 in Review
Freestone Grove Partners sold out of Alignment Healthcare (ALHC) in Q2 2026, closing a stake of 1,337,777 shares — an estimated $23.6M sold.
Freestone Grove Partners first reported a position in ALHC in Q4 2024 and held it in 5 quarters. The position peaked at $23.6M in Q1 2026. 324 funds tracked by Wall St. Rank hold ALHC as of Q2 2026.
- Freestone Grove Partners reported no remaining Alignment Healthcare position as of Q2 2026 after selling out during the quarter.
- Freestone Grove Partners sold 1,337,777 Alignment Healthcare shares in Q2 2026, an estimated $23.6M.
- Freestone Grove Partners first reported a position in Alignment Healthcare in Q4 2024 and held it in 5 quarters.
- Freestone Grove Partners's Alignment Healthcare position peaked at $23.6M in Q1 2026.
- 324 funds tracked by Wall St. Rank held Alignment Healthcare as of Q2 2026.
Based on Freestone Grove Partners's 13F filing for Q2 2026, filed 14 Aug 2026.